Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


A team of researchers from the University of Freiburg in Germany have identified previously unknown types of immune cells which are present in the inflamed brain of an animal model of multiple...
The MS Trust has launched the role of an ‘Advanced MS Champion’ to help bridge the gap in care services for people with advanced multiple sclerosis (MS). The MS Trust estimates that approximately 40,...
Researchers at Stanford University School of Medicine have proved that a system they developed a few years ago for culturing balls of stem-cell-derived human brain cells, which mimic aspects of real...
According to a recent study, linuron, a herbicide used with other herbicides, insecticides and fungicides to control the growth of grass and weeds, may be an important environmental risk factor in...
GeNeuro, a biopharmaceutical company, developing new treatments for neurological and autoimmune diseases such as multiple sclerosis (MS) and type-1 diabetes, has announced positive safety and...
Researchers from Charité - Universitätsmedizin Berlin have discovered how the body initiates repair mechanisms which will limit the extent of any damage to the myelin sheath caused by multiple...
A recent study of relapsing remitting multiple sclerosis patients treated with fingolimod, natalizumab, or alemtuzumab found they were less likely to convert to secondary progressive MS (SPMS)...
A preliminary study of nonmyeloablative Hematopoietic Stem Cell Transplantation (HSCT) has found it to be more effective than disease-modifying therapy (DMT) for patients with relapsing remitting...
Brain volume loss in multiple sclerosis (MS) is primarily driven by grey matter changes and may be independent of clinically effective treatment, a new study reports. Brain volume loss is an...
A small molecule, Sephin1, may be able to significantly delay harm to nerve cells caused by multiple sclerosis (MS) a study has shown. Nerve fibres are wrapped in a sheath of fatty tissue called...

Pages